Berberine–cinnamic acid co‐crystal effect in ameliorating hyperlipidemia might be regulated through the PI3K/AKT/mTOR/SREBP‐1 signaling pathway
Hyperlipidemia is a common chronic disease characterized by elevated levels of lipids in the blood. There is some evidence that suggests that berberine (BBR) might be beneficial for the treatment of hyperlipidemia. However, its low intestinal bioavailability limits its potential therapeutic action....
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2026-01-01
|
| Серія: | FEBS Open Bio |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/2211-5463.70115 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
